These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 29282634)

  • 1. Concise Commentary: Breathing New Life into Antisecretory Medications.
    Kavitt RT; Vaezi MF
    Dig Dis Sci; 2018 Feb; 63(2):411. PubMed ID: 29282634
    [No Abstract]   [Full Text] [Related]  

  • 2. [Influence of antacid-antisecretory drug association on changes of the gastric pH after mixed meal in normal subjects and duodenal ulcer patients].
    DODERO M; VANGOIDSENHOVEN G; ORLANDO G
    Riv Gastroenterol; 1959; 11():313-24. PubMed ID: 13817144
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antisecretory therapy as a component of hemostasis in acute gastroduodenal ulcer bleedings].
    Gostishchev VK; Evseev MA
    Khirurgiia (Mosk); 2005; (8):52-7. PubMed ID: 16091681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immediate eradication of Helicobacter pylori in patients with previously documented peptic ulcer disease: clinical and economic effects.
    Fendrick AM; McCort JT; Chernew ME; Hirth RA; Patel C; Bloom BS
    Am J Gastroenterol; 1997 Nov; 92(11):2017-24. PubMed ID: 9362183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastroprotection by antisecretory and non-antisecretory agents.
    Konturek SJ
    Klin Wochenschr; 1986; 64 Suppl 7():24-7. PubMed ID: 3560779
    [No Abstract]   [Full Text] [Related]  

  • 6. Trithiozine: a new agent for peptic ulcer and hypersecretory disorders.
    Pellegrini R; Albrici A
    Farmaco Prat; 1979 Mar; 34(3):138-40. PubMed ID: 456549
    [No Abstract]   [Full Text] [Related]  

  • 7. [Peptic ulcer--advances in drug therapy].
    Gütz HJ
    Z Arztl Fortbild (Jena); 1990; 84(16):811-3. PubMed ID: 1977243
    [No Abstract]   [Full Text] [Related]  

  • 8. Newer antisecretory agents for peptic ulcer.
    Somerville KW; Langman MJ
    Drugs; 1983 Mar; 25(3):315-30. PubMed ID: 6133734
    [No Abstract]   [Full Text] [Related]  

  • 9. Sucralfate and other non-antisecretory agents in the treatment of peptic ulcer disease.
    May B
    Methods Find Exp Clin Pharmacol; 1989; 11 Suppl 1():113-6. PubMed ID: 2657280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Potential risk of pharmacologically induced hypochlorhydria in the treatment of peptic ulcer disease].
    Ljubicić N; Rotkvić I
    Med Pregl; 1989; 42(1-2):65-8. PubMed ID: 2761484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of NSAID-associated peptic ulcer disease.
    Melcarne L; García-Iglesias P; Calvet X
    Expert Rev Gastroenterol Hepatol; 2016 Jun; 10(6):723-33. PubMed ID: 26775657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The management of the patient with peptic ulceration--an update.
    Ward M
    Aust Fam Physician; 1987 Apr; 16(4):383-5, 389-90. PubMed ID: 3593105
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antisecretory effect of losec and pariet in peptic ulcer therapy].
    Nemytin IuV; Makarov IuS; Pavlov AI; Kashchenko OI; Lezhenina NP; Golochalova TV
    Voen Med Zh; 2002 Oct; 323(10):44-6. PubMed ID: 12479006
    [No Abstract]   [Full Text] [Related]  

  • 14. Peptic ulcer medication usage, United States, 1989.
    Stat Bull Metrop Insur Co; 1990; 71(4):10-7. PubMed ID: 2237731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [HOW APPROACHES TO PHARMACOTHERAPY OF ULCER DISEASE CHANGED FOR THE LAST 30 YEARS].
    Sheptulin AA
    Klin Med (Mosk); 2015; 93(8):50-4. PubMed ID: 26669032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First-time endoscopy and use of antisecretory medication: a population-based cohort study.
    Lassen A; Hallas J; De Muckadell OB
    Scand J Gastroenterol; 2005 Jun; 40(6):705-12. PubMed ID: 16036531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical issues in the pathophysiology and management of peptic ulcer disease.
    Hunt RH; Malfertheiner P; Yeomans ND; Hawkey CJ; Howden CW
    Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):685-99. PubMed ID: 8590166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of gastric acid secretion and therapeutic results: is there any correlation?
    Corinaldesi R; Ghidini C; Ricci Maccarini M; Santaguida P; Fratesi E; Barbara G; Stanghellini V
    Ital J Gastroenterol; 1990; 22 Suppl 1():2-4. PubMed ID: 1983421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis: Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy for the prevention of recurrent bleeding from peptic ulcer.
    Gisbert JP; Khorrami S; Carballo F; Calvet X; Gene E; Dominguez-Muñoz E
    Aliment Pharmacol Ther; 2004 Mar; 19(6):617-29. PubMed ID: 15023164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of peptic ulcer in the elderly. Proton pump inhibitors and histamine H2 receptor antagonists.
    Lazzaroni M; Bianchi Porro G
    Drugs Aging; 1996 Oct; 9(4):251-61. PubMed ID: 8894523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.